NihBiotechGrantPulse / compare

UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA vs ATTICUS PHARMA INC: NihBiotechGrantPulse comparison

ATTICUS PHARMA INC's award of $1,007,121 is 1.1x UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA's $910,226 (87th percentile). UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA is dated 2026-09-14; ATTICUS PHARMA INC 2026-09-19.

Data as of · Compiled by Zalwin from NIH RePORTER (newly awarded projects)

Both records plus every comparable SC record, with all columns and source links · Card, Apple Pay, Google Pay or Link via Stripe

How does UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA compare to ATTICUS PHARMA INC?

FieldUNIVERSITY OF SOUTH CAROLINA AT COLUMBIAATTICUS PHARMA INC
OrganizationUNIVERSITY OF SOUTH CAROLINA AT COLUMBIAATTICUS PHARMA INC
LocationCOLUMBIA, SCGREENVILLE, SC
ProjectDevelopmental Research Project Program (DRPP)Phase 2: Development of an endocannabinoid microparticle formulation for the topical treatment of cutaneous manifestations of lupus erythematosus
Project number2P20GM103499-251R44AR087266-01A1
MechanismP20R44
InstituteNational Institute of General Medical SciencesNational Institute of Arthritis and Musculoskeletal and Skin Diseases
Award$910,226$1,007,121
Awarded2026-09-142026-09-19
Project period2001-09-30 to 2031-08-312026-09-25 to 2028-08-31
UEIJ22LNTMEDP73LZXUMNXR3AB5
award percentile85th87th
Lab Budget Score55/10070/100
Peer rank and all 116 SC records (CSV) 🔒 Click to unlock →
Official source URLs for every peer record 🔒 Click to unlock →

Official records: UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · ATTICUS PHARMA INC

Get newly funded labs in your territory

NihBiotechGrantPulse emails new awards matching your states, mechanisms and minimum award.

See plans

Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.

Often used together